AI assistant
Sending…
BioPorto — Director's Dealing 2017
Aug 10, 2017
3424_rns_2017-08-10_41491ca2-55d9-4c32-a4b3-339dc3ce255a.pdf
Director's Dealing
Open in viewerOpens in your device viewer
BIOPORTO®
August 10, 2017
Announcement no. 11
Managers' transactions
BioPorto A/S has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in BioPorto A/S made by persons discharging managerial responsibilities in BioPorto A/S and/or persons closely related with them.
| 1 Details of the person discharging managerial responsibilities/person closely associated | |
|---|---|
| a) Name | Thomas Magnussen |
| 2 Reason for the notification | |
| a) Position/status | Chairman of the Board |
| b) Initial notification/Amendment | Initial notification |
| 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) Name | BioPorto A/S |
| b) LEI | 5299004SWFL5JAN4W830 |
| 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) Description of the financial instrument, type of instrument Identification code | Shares DK0011048619 |
| b) Nature of the transaction | Share purchase in connection with a private placement |
| c) Price(s) and volume(s) | Price DKK 3.06, Volume 100,000 |
| d) Aggregated information | n/a |
| e) Date of the transaction | 2017-08-10 |
| f) Place of the transaction | Outside a trading venue |
BioPorto A/S • Tuborg Havnevej 15 st. • 2900 Hellerup • Denmark • [email protected] • www.bioporto.com
Phone: +45 45 29 00 00 • CVR & Vat. No. DK-17 50 03 17
More from BioPorto
Major Shareholding Notification
2026
Apr 13
Major Shareholding Notification
2026
Apr 13
Major Shareholding Notification
2026
Apr 13
Major Shareholding Notification
2026
Apr 13
M&A Activity
2026
Apr 8
M&A Activity
2026
Apr 8
Capital/Financing Update
2026
Apr 8
M&A Activity
2026
Apr 8
Regulatory Filings
2026
Mar 31
Regulatory Filings
2026
Mar 31